Bioimpacts. 2019;9(2):71-74.
  Abstract View: 281
  PDF Download: 5

Editorial

Aptamedicine: a new treatment modality in personalized cancer therapy

Abstract

Aptamers (Aps) are short single-strand nucleic acids exhibiting unique 3D structure which facilitate their targeting potential against various cancer molecular markers (CMMs). Such features of Aps not only make them as suitable targeting agents in targeted drug delivery systems (DDSs) but also candidate them as macromolecules that inhibit the interaction of the target protein with other proteins. On the other hand, the conjugation of Aps with another therapeutic molecule such as antisense oligonucleotide (AS-ODN), siRNA/miRNA, Ap, toxins, chemotherapeutic agents, DNAzyme/Ribozymes provide hopeful strategy to eradicate the malignancies and overcome the off-target unwanted side effects. Such prominent features of Aps make them a promising treatment modality to overcome the tumor complexity and heterogeneity and consequently hired toward personalized therapy of cancer by using bispecific Ap-based therapeutics.
First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 281

Your browser does not support the canvas element.


PDF Downloaded: 5

Your browser does not support the canvas element.

Submitted: 05 Sep 2018
Accepted: 05 Sep 2018
First published online: 05 Sep 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)